Explaining the relationship between race/ethnicity and pharmacy purchased syringes among injection drug users in New York City

被引:0
作者
Fuller, CM
Galea, S
Blaney, S
Ompad, DC
Deren, S
des Jarlais, D
Vlahov, D
机构
[1] Columbia Univ, Ctr Infect Dis Epidemiol Res, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY 10032 USA
[2] New York Acad Med, Ctr Urban Epidemiol Studies, New York, NY USA
[3] Natl Dev & Res Inst Inc, New York, NY USA
[4] Beth Israel Deaconess Med Ctr, Baron Edmond de Rothschild Chem Dependency Inst, New York, NY USA
关键词
HIV; injection drug use; pharmacy; racial disparities;
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objective: Pharmacy syringe sales without a prescription became legal in New York State on January 1, 2001 through the Expanded Syringe Access Demonstration Program (ESAP). At the same time, Pharmacy use among Black and Hispanic injection drug users was found to be significantly lower when compared to Whites. The purpose of this study was to assess the factors that could explain the relationship between race/ethnicity and pharmacy use. Design: Data were combined from 2 on-going injection drug user (IDU) studies in 2 New York City neighborhoods. Social and behavioral factors independently associated with ever purchasing a nonprescription syringe in the past 6 months and examined using cross-sectional logistic regression. Results: Of 33 7 IDUs, the majority were male (79%), Hispanic (73%) and had a mean age of 35 years. In bivariate analysis, IDUs who reported pharmacy use were less likely to be Black or Hispanic, older, and to have reported recent syringe exchange program (SEP) attendance compared to non-pharmacy users. Additionally, pharmacy users were more likely to have knowledge of ESAP, and report discrimination by police in the past year compared to non-users. After adjustment for recent SEP attendance (adjusted odds ratio [AOR]=0.27; 95% confidence interval [CI]=0.14-0.55), ESAP knowledge (AOR=13.11; 95% CI=6.54-26.31), discrimination by police (AOR=3.56; 95% CI=1.73-7.35), and discrimination due to race (AOR=0.25, 95% CI=0.11-0.58), race/ethnicity was not a Significant predictor of pharmacy use. Conclusions: Race/ethnicity may not be an important determinant of ESAP when more salient social circumstances, such as past discrimination, are considered. Educational efforts should be enhanced to reach those who continue to perceive barriers to ESAP.
引用
收藏
页码:589 / 596
页数:8
相关论文
共 44 条
[1]  
[Anonymous], INT J DRUG POLICY
[2]   Prejudice, clinical uncertainty and stereotyping as sources of health disparities [J].
Balsa, AI ;
McGuire, TG .
JOURNAL OF HEALTH ECONOMICS, 2003, 22 (01) :89-116
[3]   Drug use and the spread of HIV/AIDS in South America and the Caribbean [J].
Bastos, FI ;
Strathdee, SA ;
Derrico, M ;
Pina, MD .
DRUGS-EDUCATION PREVENTION AND POLICY, 1999, 6 (01) :29-49
[4]  
Bluthenthal R N, 1997, Med Anthropol, V18, P61, DOI 10.1080/01459740.1997.9966150
[5]   Characteristics and utilization patterns of needle-exchange attendees in Chicago: 1994-1998 [J].
Brahmbhatt, H ;
Bigg, D ;
Strathdee, SA .
JOURNAL OF URBAN HEALTH-BULLETIN OF THE NEW YORK ACADEMY OF MEDICINE, 2000, 77 (03) :346-358
[6]   Arrests and incarceration of injection drug users for syringe possession in Massachusetts: Implications for HIV prevention [J].
Case, P ;
Meehan, T ;
Jones, TS .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1998, 18 :S71-S75
[7]  
*CDCP, 2001, HIV AIDS SURV REP, P13
[8]  
*CDCP US DEP HLTH, 2004, FI FY 2004 GPA ANN P
[9]  
Cotten-Oldenburg NU, 2001, J ACQ IMMUN DEF SYND, V27, P183, DOI 10.1097/00126334-200106010-00014
[10]  
DESJARLAIS, 2002, J AM PHARM ASSOC, V42, pS73